Effectiveness of sodium cromoglycate in the reduction of bronchodilator doses in asthmatic patients

Effectiveness of sodium cromoglycate in the reduction of bronchodilator doses in asthmatic patients

Thirty asthmatic patients, ages ranging from 6 to 72 years, who were submitted to a 14 weeks clinical evaluation, were studied measuring the severity of dysnea, coughing, expectoration and wheezing. Sodium chromoglycate (SCG) was administered in aerosol starting the second week of the study and the...

Full description

Saved in:
Bibliographic Details
Published in:Revista alergia : organo oficial de la Sociedad Mexicana de Alergia e Inmunlogia Vol. 39; no. 4; p. 74
Main Authors: Bolaños Ancona, J C, Espinosa Morales, S M, Miranda Feria, A J
Format: Journal Article
Language:Spanish
Published: Mexico 01-07-1992
Subjects:
Adolescent
Adult
Aged
Asthma - drug therapy
Bronchodilator Agents - administration & dosage
Bronchodilator Agents - therapeutic use
Child
Cromolyn Sodium - pharmacology
Cromolyn Sodium - therapeutic use
Drug Synergism
Female
Humans
Male
Middle Aged
Prospective Studies
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Thirty asthmatic patients, ages ranging from 6 to 72 years, who were submitted to a 14 weeks clinical evaluation, were studied measuring the severity of dysnea, coughing, expectoration and wheezing. Sodium chromoglycate (SCG) was administered in aerosol starting the second week of the study and the doses of bronchial dilators was reduced starting the fourth week, with a 25% decrease in the total established initial dosage, every two weeks. In this study, SCG showed to be useful in decreasing symptoms caused by bronchial hyperreactivity and the use of bronchial dilators in 70% of asthmatics who react with the presence of just one risk factor (cold, the most frequent).